DeepMed Research

Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Implementing a Family Caregiver Checklist in Primary Care: A Pilot Study

Not Applicable

Completed

Conditions: Caregiver Burnout

Interventions: Behavioral: Usual Care
Behavioral: Collaborative Healthcare Encounters with Caregivers (CHEC)

First Posted Date: 2021-07-01

Last Posted Date: 2025-01-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 111

Registration Number: NCT04946942

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Phase 1

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: 225Ac-J591
Drug: Pembrolizumab
Drug: Androgen receptor pathway inhibitor
Diagnostic Test: 68Ga-PSMA-11

First Posted Date: 2021-06-30

Last Posted Date: 2024-10-16

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 76

Registration Number: NCT04946370

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
New York Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸
New York Presbyterian/Weill Cornell Medical Center, New York, New York, United States

and more 1 locations

Validity of a Test of Functional Cognition in Persons With Acquired Brain Injury

Completed

Conditions: Acquired Brain Injury

First Posted Date: 2021-06-29

Last Posted Date: 2021-06-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 73

Registration Number: NCT04943835

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

Phase 4

Completed

Conditions: Nail Diseases

Interventions: Device: Platelet-poor plasma
Device: Platelet-rich plasma

First Posted Date: 2021-06-28

Last Posted Date: 2024-04-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 11

Registration Number: NCT04941807

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Delirium in Children Undergoing Stem Cell Transplantation

Active, not recruiting

Conditions: Delirium
Stem Cell Transplant Complications

Interventions: Other: Daily screening for delirium

First Posted Date: 2021-06-24

Last Posted Date: 2024-07-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1041

Registration Number: NCT04937400

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
St Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 3 locations

Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy

Early Phase 1

Conditions: STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder
Developmental and Epileptic Encephalopathy

Interventions: Drug: Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]

First Posted Date: 2021-06-23

Last Posted Date: 2025-01-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT04937062

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Phase 2

Terminated

Conditions: Thymic Carcinoma

Interventions: Drug: KN046

First Posted Date: 2021-06-14

Last Posted Date: 2024-04-16

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4

Registration Number: NCT04925947

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Web-based Family History Tool

Not Applicable

Completed

Conditions: Breast Cancer
BRCA2 Mutation
Gynecologic Cancer
BRCA1 Mutation

Interventions: Other: Web-based family health history tool

First Posted Date: 2021-05-18

Last Posted Date: 2023-03-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 250

Registration Number: NCT04890327

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

Not Applicable

Recruiting

Conditions: Mammaplasty
Mastectomy
Breast Reconstruction

Interventions: Device: REVOLVE Advanced Adipose System
Procedure: Viality
Device: LipoGrafter

First Posted Date: 2021-05-18

Last Posted Date: 2025-04-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 135

Registration Number: NCT04891510

Locations: 🇺🇸
New York Presbyterian - Weill Cornell Medicine, New York, New York, United States

Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment

Completed

Conditions: Prostate Cancer

Interventions: Other: Patient-reported questionnaire

First Posted Date: 2021-05-18

Last Posted Date: 2025-05-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1953

Registration Number: NCT04890314

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
New York State Department of Health, Albany, New York, United States
🇺🇸
University of Kansas, Kansas City, Kansas, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy